Optically-controlled bacterial metabolite for cancer therapy
2018 · Nature Communications · 316 citations
https://doi.org/10.1038/s41467-018-03233-9
D
Diwei Zheng
University of Electronic Science and Technology of China(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
8.1K
Citations
47
h-index
87
i10-index
Diwei Zheng is an academic researcher from University of Electronic Science and Technology of China. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Nanoparticle-Based Drug Delivery & Immune Cell Function and Interaction. The author has an h-index of 47, co-authored 97 publications.
ORCID: 0000-0001-8888-9630Papers by this author
worksPrebiotics‐Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer
2020 · Advanced Materials · 255 citations
https://doi.org/10.1002/adma.202004529
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
2019 · Journal of Hematology & Oncology · 137 citations
https://doi.org/10.1186/s13045-019-0704-y
Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis
2024 · Cell Host & Microbe · 118 citations
https://doi.org/10.1016/j.chom.2024.07.028
A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy
2020 · Nature Communications · 76 citations
https://doi.org/10.1038/s41467-020-15927-0
Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells
2021 · Oncogene · 76 citations
https://doi.org/10.1038/s41388-020-01605-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat